Switch to:
More From Other Websites
Colorado important to an enlarged Medtronic Jan 29 2015
With acquisition completed, Medtronic moves on Jan 29 2015
Studies Show Benefits of Medtronic SmartShock(TM) Technology and Physician Reports in Protecting... Jan 29 2015
Studies Show Benefits of Medtronic SmartShock(TM) Technology and Physician Reports in Protecting... Jan 29 2015
Medtronic CoreValve safer than surgery in bypass patients -study Jan 28 2015
Medtronic Study Finds CoreValve® System Benefits Aortic Stenosis Patients with Prior Coronary... Jan 28 2015
Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill Jan 28 2015
Medtronic completes blockbuster buy of Covidien; both companies big in Colorado Jan 27 2015
Covidien International Finance S.A. -- Moody's upgrades Covidien's long term rating to A3 from Baa1;... Jan 27 2015
Medtronic, Inc. -- Moody's downgrades Medtronic's ratings to A3 from A2; outlook negative Jan 27 2015
Medtronic Completes Covidien Acquisition for $50B - Analyst Blog Jan 27 2015
Medtronic closes on Covidien deal: CEO Jan 27 2015
With Covidien-Medtronic merger final, attention turns to cost-cutting Jan 27 2015
Medtronic: the tax inversion that got away Jan 27 2015
MEDTRONIC INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles... Jan 27 2015
Medtronic Completes Acquisition of Covidien Jan 26 2015
Medtronic Completes Acquisition of Covidien Jan 26 2015
Medtronic’s Strategy Takes Shape After Biggest Inversion Ever Jan 26 2015
Medtronic's Pending Acquisition of Covidien Approved by Irish High Court Jan 26 2015
Medtronic's Pending Acquisition of Covidien Approved by Irish High Court Jan 26 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK